前列腺癌主动监测的障碍和促进因素 - 临床医生的定性研究。
Barriers and enablers of active surveillance for prostate cancer - a qualitive study of clinicians.
发表日期:2023 Sep 11
作者:
Trent A Pattenden, Isaac A Thangasamy, Wee Loon Ong, Dhanika Samaranayke, Andrew Morton, Declan G Murphy, Susan Evans, Jeremy Millar, Venu Chalasani, Prem Rashid, Matthew Winter, Ian Vela, David Pryor, Stephen Mark, Stacy Loeb, Nathan Lawrentschuk, Elizabeth Pritchard
来源:
BJU INTERNATIONAL
摘要:
为了识别和探索医生对低风险前列腺癌患者主动观察(AS)的障碍和促进因素,本研究采用澳大利亚和新西兰的泌尿外科医生和放射营养师进行了有选择性的交叉调查。以性别和实践环境(大都市/地区;公立/私立)为基础,使用以基础理论方法为基础的半结构化访谈与参与者进行了讨论。独立的两名研究人员使用开放、轴向和选择性编码对访谈内容进行了编码。采用不断比较的方法分析数据,并在进行数据采集后达到主题饱和。根据临床医生的看法,对患有前列腺癌的患者进行了关于AS的障碍和促进因素的详细模型的开发。
一个关于临床医生在低风险前列腺癌AS中做决策的模型出现了。它包括三个宏观主题:(一)临床医生对患者阻碍和促进因素的看法;(二)临床医生对自身阻碍和促进因素的看法;(三)与医疗团队和资源可用性的互动。
临床医生一致认为AS是管理低风险前列腺癌的证据支持方法。尽管如此,很多男性没有进行AS,这是由于患者和临床医生因素的相互作用以及他们与更广泛医疗系统的互动。本研究确定了减轻障碍和增强促进因素的策略,这可以增加低风险前列腺癌患者接受AS的机会。
本文章受版权保护,保留一切权利。
To identify and explore barriers to, and enablers of active surveillance (AS) in men with low-risk prostate cancer (LRPC), as perceived by prostate cancer clinicians.Urologists and radiation oncologists in Australia and New Zealand were purposively sampled for a cross-section on gender and practice setting (metropolitan/regional; public/private). Using a grounded theory approach, semi-structed interviews were conducted with participants. Interviews were coded independently by two researchers using open, axial and selective coding. A constant comparative approach was used to analyse data as it was collected. Thematic saturation was reached after 18 interviews, and a detailed model of barriers to, and enablers of, AS for prostate cancer, as perceived by clinicians was developed.A model explaining what affects clinician decision making regarding AS in LRPC emerged. It was underpinned by three broad themes: (i) clinician perception of patients' barriers and enablers; (ii) clinician perception of their own barriers and enablers; and (iii) engagement with healthcare team and resource availability.Clinicians unanimously agree that AS is an evidence-based approach for managing LRPC. Despite this many men do not undergo AS for LRPC, which is due to the interplay of patient and clinician factors, and their interaction with the wider healthcare system. This study identifies strategies to mitigate barriers and enhance enablers, which could increase access to AS by patients with LRPC.This article is protected by copyright. All rights reserved.